跳至主要内容
临床试验/NCT07651397
NCT07651397尚未招募不适用

Open Labeled , Randomized, Controlled, Crossover Trial on the Effect of a Carbohydrate Restricted Plant Dominant Diet on MCP-1 Mediated Inflammatory Signaling in Autosomal Dominant Polycystic Kidney Disease

Assaf-Harofeh Medical Center0 个研究点目标入组 36 人开始时间: 2026年7月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
36
主要终点
Change in Urinary MCP-1/Creatinine Ratio

研究概览

简要总结

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst growth and declining kidney function. Inflammatory pathways, including those mediated by monocyte chemoattractant protein-1 (MCP-1), are increasingly recognized as contributors to disease progression. Metabolic alterations in cystic epithelial cells may influence inflammatory signaling, suggesting a potential role for dietary interventions targeting metabolic pathways.

This study is a prospective, randomized, open-label crossover trial designed to evaluate the effect of a carbohydrate restricted, plant dominant dietary intervention on urinary MCP-1 levels in adults with ADPKD. Participants will be randomized to one of two sequences: dietary intervention followed by usual diet, or usual diet followed by dietary intervention, with a washout period between study phases. Each study period will last 12 weeks.

The primary objective is to assess within subject differences in urinary MCP-1/creatinine ratio between the dietary intervention and usual diet conditions. Secondary outcomes include measures of metabolic parameters, insulin resistance, dietary adherence, and safety.

This study aims to explore whether a structured dietary approach may influence intrarenal inflammatory activity in ADPKD and provide preliminary data to inform future interventional studies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of ADPKD based on established clinical or genetic criteria (PKD 1/PKD2)
  • Estimated glomerular filtration rate (eGFR) between 45 and 90 mL/min/1.73 m²
  • Mayo Imaging Classification class 1C-1E based on MRI-derived height-adjusted total kidney volume.
  • Stable kidney function, defined as no acute kidney injury and no decline in eGFR >20% within the preceding 3 months
  • Stable antihypertensive and chronic medications for at least 4 weeks prior to enrollment
  • Ability and willingness to adhere to the prescribed dietary intervention
  • Ability to provide written informed consent

排除标准

  • eGFR <45 mL/min/1.73 m² or requirement for dialysis
  • History of kidney transplantation
  • Significant albuminuria, defined as urine albumin to creatinine ratio (UACR) >300 mg/g
  • Poorly controlled or unstable diabetes mellitus (e.g., HbA1c >8% or clinically significant glycemic variability or frequent hypoglycemia)
  • Use of Tolvaptan at the time of screening or within the study period
  • Current adherence to a ketogenic or carbohydrate restricted diet
  • Unintentional weight loss >5% within the preceding 3 months
  • Active infection, inflammatory disease, or malignancy that may influence inflammatory markers
  • Current use of systemic corticosteroids or immunosuppressive therapy
  • Active or symptomatic nephrolithiasis
  • Serum bicarbonate <20 mmol/L
  • Pregnancy or breastfeeding
  • Known eating disorder or condition limiting adherence to dietary interventions
  • Participation in another interventional study within the previous 3 months
  • Any condition that, in the opinion of the investigators, would interfere with study participation or interpretation of results

研究组 & 干预措施

Sequence A: Dietary Intervention → Usual Diet

Experimental

Participants receive a carbohydrate restricted, plant dominant diet for 12 weeks, followed by a washout period and then usual diet for 12 weeks.

干预措施: Carbohydrate Restricted, Plant Dominant Diet (Behavioral)

Sequence B: Usual Diet → Dietary Intervention

Experimental

Participants follow their usual diet for 12 weeks, followed by a washout period and then the dietary intervention for 12 weeks.

干预措施: usual diet (Behavioral)

Sequence B: Usual Diet → Dietary Intervention

Experimental

Participants follow their usual diet for 12 weeks, followed by a washout period and then the dietary intervention for 12 weeks.

干预措施: Carbohydrate Restricted, Plant Dominant Diet (Behavioral)

Sequence A: Dietary Intervention → Usual Diet

Experimental

Participants receive a carbohydrate restricted, plant dominant diet for 12 weeks, followed by a washout period and then usual diet for 12 weeks.

干预措施: usual diet (Behavioral)

结局指标

主要结局

Change in Urinary MCP-1/Creatinine Ratio

时间窗: Baseline and End of each 12-week study period (weeks 0,12, 18 and 30)

Urinary MCP-1 levels will be measured in first morning urine samples and normalized to urine creatinine (MCP-1/creatinine ratio). For each study period, two samples will be collected within the final week (2-5 days apart), and the mean value will be used. The primary outcome is the within subject difference in MCP-1/creatinine ratio between the dietary intervention and usual diet conditions.

次要结局

  • Association Between Carbohydrate Intake and MCP-1(Baseline and End of each 12-week study period (weeks 0,12, 18 and 30))
  • Association Between Change in HOMA-IR and MCP-1(Baseline and End of each 12-week study period (weeks 0,12, 18 and 30))
  • Dietary Adherence and MCP-1 Response(Baseline and End of each 12-week study period (weeks 0,12, 18 and 30))
  • Change in Metabolic and Biochemical Parameters (Safety Outcomes)(Baseline and End of each 12-week study period (weeks 0,12, 18 and 30))

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Elad Nizri

MEDICAL DOCTOR, NEPHROLOGIST

Assaf-Harofeh Medical Center

相似试验